Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2009
11/03/2009CA2384925C Process for the preparation of oxazole derivatives
11/03/2009CA2341291C Pyridine ketones useful as herbicides
10/2009
10/29/2009WO2009132202A2 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009WO2009132136A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009WO2009132093A2 Substituted arylcyclopentenes as therapeutic agents
10/29/2009WO2009132000A1 Quinoline or isoquinoline substituted p2x7 antagonists
10/29/2009WO2009131957A2 Compounds, compositions and methods comprising oxadiazole derivatives
10/29/2009WO2009131654A2 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
10/29/2009WO2009131246A1 Sordarin derivatives for preventing or treating infectious diseases caused by pathogenic microorganisms
10/29/2009WO2009131237A1 Harmful arthropod control composition, and fused heterocyclic compound
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131173A1 2-aminoquinazoline derivative
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131090A1 Amino acid compound
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130496A1 Substituted pyrimidin-5-carboxamides 281
10/29/2009WO2009130469A1 Dna-pk inhibitors
10/29/2009WO2009130193A1 Fungicide hydroximoyl-heterocycles derivatives
10/29/2009WO2009129954A2 2-[(1h-pyrazole-4-ylmethyl)-sulfonyl]-oxazole derivatives, 2-[(1h-pyrazole-4-ylmethyl)-sulfanyl]-oxazole derivatives, and chiral 2-[(1h-pyrazole-4-ylmethyl)-sulfinyl]-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/29/2009WO2009129953A1 2-(benzylsulfonyl)-oxazole derivatives, chiral 2- (benzylsulfinyl) -oxazole derivatives and 2-(benzylsulfanyl)-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/29/2009WO2009129945A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
10/29/2009WO2009106980A3 Indazole derivatives
10/29/2009US20090270621 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
10/29/2009US20090270616 Aryl sulfonamides
10/29/2009US20090270468 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/29/2009US20090270464 Benzimidazole derivative and use as a II receptor antagonist
10/29/2009US20090270433 2,3-dihydro-iminoisoindole derivatives
10/29/2009US20090270407 Fungicidal isoxazolidines
10/29/2009US20090270394 Cyclylamine derivatives as calcium channel blockers
10/29/2009US20090270393 Iminopyridine Derivatives and Use Thereof
10/29/2009US20090270392 prostaglandin EP2 receptor agonists for treating baldness, glaucoma, post-surgical and post-laser trabeculectomy ocular hypertensive episodes, inflammatory bowel disease, and as presurgical adjuncts
10/29/2009US20090270391 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-MET AUTOPHOSPHORYLATION INHIBITING POTENCY
10/29/2009US20090270390 Pyrimidine derivatives
10/29/2009US20090270387 Substituted arylcyclopentenes as therapeutic agents
10/29/2009US20090270386 Therapeutic compounds
10/29/2009US20090270385 useful in treating vision defects, inflammatory bowel disease, alopecia, the stimulation of hair growth and the stimulation of the conversion of vellus hair to terminal hair
10/29/2009US20090270384 Morpholine dopamine agonists
10/29/2009US20090270382 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270381 Non-steroidal progesterone receptor modulators
10/29/2009US20090270374 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090270371 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270362 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
10/29/2009US20090270360 Dicarboxamide derivatives
10/29/2009US20090270359 Substituted pyrazole derivatives
10/29/2009US20090269420 Substituted dihydropyrazolones and their use
10/29/2009DE102007049630A1 New amide compounds used for therapy and/or prophylaxis of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy
10/29/2009CA2722403A1 Substituted arylcyclopentenes as therapeutic agents
10/29/2009CA2722326A1 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009CA2722227A1 2-[(1h-pyrazole-4-ylmethyl)-sulfonyl]-oxazole derivatives, 2-[(1h-pyrazole-4-ylmethyl)-sulfanyl]-oxazole derivatives, and chiral 2-[(1h-pyrazole-4-ylmethyl)-sulfinyl]-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/29/2009CA2722214A1 2-(benzylsulfonyl)-oxazole derivatives, chiral 2- (benzylsulfinyl) -oxazole derivatives and 2-(benzylsulfanyl)-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/29/2009CA2722139A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722035A1 Quinoline or isoquinoline substituted p2x7 antagonists
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2721270A1 Harmful arthropod control composition, and fused heterocyclic compound
10/29/2009CA2719936A1 Substituted pyrimidin-5-carboxamides 281
10/28/2009EP2112149A1 2-[(1H-Pyrazol-4-ylmethyl)-sulfonyl]-oxazole derivatives, 2-[(1H-pyrazol-4-ylmethyl)-sulfanyl]-oxazole derivatives and chiral 2-[(1H-pyrazol-4-ylmethyl)-sulfinyl]-oxazole derivatives, method for production of same and their use as herbicides and plant growth regulators
10/28/2009EP2112143A1 2-(benzylsulfonyl)-oxazol-derivatives, chiral 2-(benzylsulfinyl]-oxazol derivatives, 2-(benzylsulfanyl-oxazol) derivatives, process for their preparation, as well as their use as herbicide and plant growth regulators
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP1633717B1 P2x7 receptor antagonists and their use
10/28/2009EP1631548B1 Inhibitors of akt activity
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101568534A Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through GLK
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608619 [{4-[(4-benzyl-5-pyrrolidin-1-yl-oxazol-2-yl)-piperidin-1-yl-methyl]-cyclohexyl}-(4-fluorophenyl)-methyl]-dimethylamine; depression, urinary incontinence, diarrhoea, pruritus, alcohol and drug misuse, drug dependency, acute pain, neuropathic pain or chronic pain and anxiety
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608617 N,N-alkylene-6-(piperidin-1-ylalkoxy)naphthalene-2-carboxamide derivatives, e.g., piperidin-1-yl-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone and 3,4-dihydro-1H-isoquinolin-2-yl)-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone; especially for treating obesity
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/27/2009US7608563 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same
10/27/2009CA2567935C Aminopyridine derivatives as selective dopamine d3 agonists
10/27/2009CA2506441C 5-substituted-pyrazine or pyridine glucokinase activators
10/27/2009CA2379021C New phenylpiperazines
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2363792C Percutaneous absorption preparation of compound having angiotensin ii antagonistic activity
10/27/2009CA2361174C 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009WO2009129036A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
10/22/2009WO2009128661A2 A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128390A1 Method for producing optically active cyanohydrin compound
10/22/2009WO2009127949A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127948A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127946A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127944A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127943A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127686A1 Novel estrogen receptor ligands
10/22/2009WO2009127642A2 Use of lrrk2 inhibitors for neurodegenerative diseases
10/22/2009WO2009127546A1 Pyrrolidinone glucokinase activators
10/22/2009WO2009127417A1 Quinoline derivatives as axl kinase inhibitors
10/22/2009US20090264653 Useful indole compounds
10/22/2009US20090264650 Prophylactic/Therapeutic Agent for Diabetes
10/22/2009US20090264649 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
10/22/2009US20090264485 Pyrazole Derivatives, Their Manufacture and Their Use as Pharmaceutical Agents
10/22/2009US20090264473 Novel Crystalline Forms of Antidiabetic Compounds
10/22/2009US20090264451 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/22/2009US20090264441 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 647